Abstract:To investigate the in vitro effects of cytosine deaminase-thymidine kinase/5-fluorocytosine + ganciclovir (CD-TK/5-FC + GCV) on ovarian cancer cells and normal cells using a human telomerase reverse transcriptase (hTERT) promoter-driven vector system.hTERT promoter activity was determined by luciferase assay after the plasmids of pBTdel-279 containing hTERT core promoter were transfected into ovarian carcinoma-derived cell line 3AO, human normal ovarian epithelial cell (NOEC) and human embryonic lung fibroblast (HELF). hTERT mRNA expression levels of these cells were determined by reverse transcription polymerase chain reaction (RT-PCR). Eukaryotic expression vectors containing CD-TK fusion disuicide genes under the control of hTERT promoter (pBTdel-279-CD-TK) and cytomegalovirus (CMV) promoter (pcDNA3-CD-TK), as well as vectors containing TK gene under hTERT promoter control (pBTdel-279-TK), were constructed and transfected into 3AO, NOEC and HELF cells by cationic liposome. Following the transfection with CD and TK, 5-FC and GCV of different doses were added and methyl thiazolyl tetrazolium (MTT) and flow cytometry methods were applied to investigate the antitumor effects of pBTdel-279-CD-TK/5-FC + GCV and pcDNA3-CD-TK/5-FC + GCV systems. pBTdel-279-TK/GCV was considered as a control. RT-PCR was used to detect CD and TK genes in ovarian cancer cells and normal cells before and after the transfection of pBTdel-279-CD-TK or pcDNA3-CD-TK. Scanning electron microscopy (SEM) was used to examine the morphology of 3AO after the action of pBTdel-279-CD-TK/5-FC + GCV.hTERT promoter activity was 24.1% and hTERT mRNA expression was positive in ovarian cancer cell 3AO, whereas in NOEC or HELF the activity was 0.3% or 0.7% and hTERT mRNA expression was negative. Expression vectors of pBTdel-279-CD-TK, pcDNA3-CD-TK and pBTdel-279-TK were successfully constructed. Compared with the effects of pBTdel-279-TK/GCV, the pBTdel-279-CD-TK/5-FC + GCV system was more efficient on hTERT positive ovarian cancer cells, but had no effects on hTERT-negative NOEC and HELF cells. The killing rate was 74.5% when 5-FC was at 2 mmol/L and GCV at 10 mg/L. The hTERT promoter system was nearly as efficient as the CMV promoter system in inducing cancer cell death (P > 0.05). CD and TK genes were expressed in all the three kinds of cells after pcDNA3-CD-TK transfection, while positive only in ovarian cancer cells after pBTdel-279-CD-TK transfection. Apoptosis was the major death form of 3AO following the effects of pBTdel-279-CD-TK/5-FC + GCV.The telomerase-specific expression of CD and TK genes under the hTERT promoter control is a novel targeting approach for gene therapy of ovarian cancer.

In vitro research of enhanced suicide gene vector for cervix cancer therapy

In Vivo and in Vitro Experimental Study on Cervix Cancer with Combination of HSV-TK/GCV Suicide Gene Therapy System and 60 Co Radiotherapy

The Selective Killing Effect of Adenoviral Mediated CD/5 -FC Suicide Gene System Controlled by Htert Promoter on Ovarian Cancer Cells

Antitumor Effects of Recombinant Vectors Carrying CDglyTK Suicide Gene on Nasopharyngeal Carcinoma Cell in Vitro

An Experimental Study on Targeting Suicide Gene Therapy for Lung Cancer with HSV-TK Driven by hTERT Promoter

In Vitro And In Vivo Tissue Specific Cytotoxicity Of Gastric Cancer Cells Resulting From Cd:Uprt/5-Fc Gene Therapy System Driven By Htert Promoter

In vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for PC-3 cell line

In vitro antitumor effect of CD, TK fusion suicide gene induced by adenovirus vector

In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter

Lentivirus-mediated Gene Transfer of Human Strail Induced Apoptosis in SGC-7901 Cells

Construction of two plasmids mediating suicide gene for treatment of hepatocellular carcinomain vitro

[In Vitro Experimental Study of Killing Hep-2 Cells of Laryngeal Cancer with Suicide Fusion Gene CDglyTK].

Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene.

Enhanced Suicide Gene Therapy Using A Tumor-Specific Promoter in Combination with Cisplatin

Novel Non-Viral Vector-Mediated Fusion Suicide Gene Targeted Therapy of Gastric Carcinoma Experimental Study

Anti-hepatoma effect of suicide gene therapy using HSV/TK combined with ganciclovir in hepatoma cells

Selective Killing Effect of Cytosine Deaminase Gene Controlled by Human Telomerase Reverse Transcriptase Promoter on Cervical Cancer Cells

Tumor Cell Apoptosis Induced by HSV-tk Suicide Gene in Mediation of VEGF Htert Multiple Regulatory Sequence

Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.

Tissue specific cytotoxicity of colon cancer cells mediated by nanoparticle-delivered suicide gene in vitro and in vivo.

TK Gene Combined with Mil-2 and Mgm-Csf Genes in Treatment of Gastric Cancer